Proposed device ID rule may result in changes to packaging lines

01/1/2013 | Packaging World online

The FDA's proposal to set up a unique device identifier system for medical technologies will compel firms to modify their packaging lines, which could be costly, according to this article. The FDA Safety and Innovation Act mandates that a final rule on the proposal be issued in the middle of May, not the middle of June as previously thought, but the agency "doesn't seem to be confident of meeting either possible deadline," said AdvaMed's Vice President of Technology and Regulatory Affairs Jeffrey Secunda.

View Full Article in:

Packaging World online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA